Rationale for clinical trials of coagulation: reactive drugs in hepatocellular carcinoma.

about

Growth factor- and heparin-dependent regulation of constitutive and agonist-mediated human endothelial barrier function.

P2860

Q40282850-1197CF93-90B4-465B-9DCB-A56BFCE92C8F

P2860

Rationale for clinical trials of coagulation: reactive drugs in hepatocellular carcinoma.

Item

http://www.wikidata.org/entity/Q35879110

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Rationale for clinical trials of coagulation: reactive drugs in hepatocellular carcinoma.

@ast

Rationale for clinical trials of coagulation: reactive drugs in hepatocellular carcinoma.

@en

type

Item

label

Rationale for clinical trials of coagulation: reactive drugs in hepatocellular carcinoma.

@ast

Rationale for clinical trials of coagulation: reactive drugs in hepatocellular carcinoma.

@en

prefLabel

Rationale for clinical trials of coagulation: reactive drugs in hepatocellular carcinoma.

@ast

Rationale for clinical trials of coagulation: reactive drugs in hepatocellular carcinoma.

@en

P1476

Rationale for clinical trials of coagulation: reactive drugs in hepatocellular carcinoma.

@en

P2093

Leo R Zacharski

http://www.w3.org/2001/XMLSchema#string

Merten Hommann

http://www.w3.org/2001/XMLSchema#string

Roland Kaufmann

http://www.w3.org/2001/XMLSchema#string

P2860

The dysfibrinogenaemias

Serum midkine levels are increased in patients with various types of carcinomas

Hepatitis C Virus RNA Synthesis in a Cell-Free System Isolated from Replicon-Containing Hepatoma Cells

Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans

Expression of hepatoma-derived growth factor in hepatocarcinogenesis

Substrate specificity of heparanases from human hepatoma and platelets

Expression of heparin-binding epidermal growth factor-like growth factor in the hepatocytes of fibrotic rat liver during hepatocarcinogenesis

Expression patterns and different subcellular localization of the growth factors HDGF (hepatoma-derived growth factor) and HRP-3 (HDGF-related protein-3) suggest functions in addition to their mitogenic activity

Hepatocellular carcinoma

Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells.

P304

777-784

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14779072.2.5.777

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8363872

http://www.w3.org/2001/XMLSchema#string

P698

15350179

http://www.w3.org/2001/XMLSchema#string

Rationale for clinical trials of coagulation: reactive drugs in hepatocellular carcinoma.

about

P2860

P2860

Rationale for clinical trials of coagulation: reactive drugs in hepatocellular carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698